Dectin-1-activated dendritic cells trigger potent antitumour immunity through the induction of Th9 cells.
Dectin-1-activated dendritic cells trigger potent antitumour immunity through the induction of Th9 cells.
复制标题
Dectin-1 激活的树突状细胞通过诱导 Th9 细胞触发有效的抗肿瘤免疫
DOI:
10.1038/ncomms12368
复制
发表时间:
2016-08-05
影响因子:
16.6
通讯作者:
Wang S
中科院分区:
文献类型:
--
作者:
Zhao Y;Chu X;Chen J;Wang Y;Gao S;Jiang Y;Zhu X;Tan G;Zhao W;Yi H;Xu H;Ma X;Lu Y;Yi Q;Wang S
Dectin-1 signalling in dendritic cells (DCs) has an important role in triggering protective antifungal Th17 responses. However, whether dectin-1 directs DCs to prime antitumour Th9 cells remains unclear. Here, we show that DCs activated by dectin-1 agonists potently promote naive CD4+ T cells to differentiate into Th9 cells. Abrogation of dectin-1 in DCs completely abolishes their Th9-polarizing capability in response to dectin-1 agonist curdlan. Notably, dectin-1 stimulation of DCs upregulates TNFSF15 and OX40L, which are essential for dectin-1-activated DC-induced Th9 cell priming. Mechanistically, dectin-1 activates Syk, Raf1 and NF-κB signalling pathways, resulting in increased p50 and RelB nuclear translocation and TNFSF15 and OX40L expression. Furthermore, immunization of tumour-bearing mice with dectin-1-activated DCs induces potent antitumour response that depends on Th9 cells and IL-9 induced by dectin-1-activated DCs in vivo. Our results identify dectin-1-activated DCs as a powerful inducer of Th9 cells and antitumour immunity and may have important clinical implications. Dendritic cells instruct different types of T cell responses depending on the types of microbial ligands sensed. Here the authors show that dendritic cells stimulated via Dectin-1 receptor upregulate TNFSF15 and OX40L and induce T helper 9 response and efficient antitumour immunity in mouse models.